Literature DB >> 20404324

Catalytic mechanism of heparinase II investigated by site-directed mutagenesis and the crystal structure with its substrate.

David Shaya1, Wenjing Zhao, Marie-Line Garron, Zhongping Xiao, Qizhi Cui, Zhenqing Zhang, Traian Sulea, Robert J Linhardt, Miroslaw Cygler.   

Abstract

Heparinase II (HepII) is an 85-kDa dimeric enzyme that depolymerizes both heparin and heparan sulfate glycosaminoglycans through a beta-elimination mechanism. Recently, we determined the crystal structure of HepII from Pedobacter heparinus (previously known as Flavobacterium heparinum) in complex with a heparin disaccharide product, and identified the location of its active site. Here we present the structure of HepII complexed with a heparan sulfate disaccharide product, proving that the same binding/active site is responsible for the degradation of both uronic acid epimers containing substrates. The key enzymatic step involves removal of a proton from the C5 carbon (a chiral center) of the uronic acid, posing a topological challenge to abstract the proton from either side of the ring in a single active site. We have identified three potential active site residues equidistant from C5 and located on both sides of the uronate product and determined their role in catalysis using a set of defined tetrasaccharide substrates. HepII H202A/Y257A mutant lost activity for both substrates and we determined its crystal structure complexed with a heparan sulfate-derived tetrasaccharide. Based on kinetic characterization of various mutants and the structure of the enzyme-substrate complex we propose residues participating in catalysis and their specific roles.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20404324      PMCID: PMC2888417          DOI: 10.1074/jbc.M110.101071

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

Review 1.  Specificities of heparan sulphate proteoglycans in developmental processes.

Authors:  N Perrimon; M Bernfield
Journal:  Nature       Date:  2000-04-13       Impact factor: 49.962

2.  Crystal structure of alginate lyase A1-III complexed with trisaccharide product at 2.0 A resolution.

Authors:  H J Yoon; W Hashimoto; O Miyake; K Murata; B Mikami
Journal:  J Mol Biol       Date:  2001-03-16       Impact factor: 5.469

3.  Active site of chondroitin AC lyase revealed by the structure of enzyme-oligosaccharide complexes and mutagenesis.

Authors:  W Huang; L Boju; L Tkalec; H Su; H O Yang; N S Gunay; R J Linhardt; Y S Kim; A Matte; M Cygler
Journal:  Biochemistry       Date:  2001-02-27       Impact factor: 3.162

4.  Development of a genetic system for the transfer of DNA into Flavobacterium heparinum.

Authors:  Hongsheng Su; Zhongqi Shao; Lydia Tkalec; Françoise Blain; Joe Zimmermann
Journal:  Microbiology       Date:  2001-03       Impact factor: 2.777

5.  Synthesis of thrombin-inhibiting heparin mimetics without side effects.

Authors:  M Petitou; J P Hérault; A Bernat; P A Driguez; P Duchaussoy; J C Lormeau; J M Herbert
Journal:  Nature       Date:  1999-04-01       Impact factor: 49.962

6.  Structural basis of hyaluronan degradation by Streptococcus pneumoniae hyaluronate lyase.

Authors:  S Li; S J Kelly; E Lamani; M Ferraroni; M J Jedrzejas
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

7.  Crystal structure of chondroitin AC lyase, a representative of a family of glycosaminoglycan degrading enzymes.

Authors:  J Féthière; B Eggimann; M Cygler
Journal:  J Mol Biol       Date:  1999-05-14       Impact factor: 5.469

8.  A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry.

Authors:  D Shukla; J Liu; P Blaiklock; N W Shworak; X Bai; J D Esko; G H Cohen; R J Eisenberg; R D Rosenberg; P G Spear
Journal:  Cell       Date:  1999-10-01       Impact factor: 41.582

9.  Crystal structure of chondroitinase B from Flavobacterium heparinum and its complex with a disaccharide product at 1.7 A resolution.

Authors:  W Huang; A Matte; Y Li; Y S Kim; R J Linhardt; H Su; M Cygler
Journal:  J Mol Biol       Date:  1999-12-17       Impact factor: 5.469

Review 10.  Enhanced bacterial virulence through exploitation of host glycosaminoglycans.

Authors:  Franco D Menozzi; Kevin Pethe; Pablo Bifani; Fabrice Soncin; Michael J Brennan; Camille Locht
Journal:  Mol Microbiol       Date:  2002-03       Impact factor: 3.501

View more
  20 in total

1.  Asparagine 405 of heparin lyase II prevents the cleavage of glycosidic linkages proximate to a 3-O-sulfoglucosamine residue.

Authors:  Wenjing Zhao; Marie-Line Garron; Bo Yang; Zhongping Xiao; Jeffrey D Esko; Miroslaw Cygler; Robert J Linhardt
Journal:  FEBS Lett       Date:  2011-07-06       Impact factor: 4.124

2.  Updates to the Symbol Nomenclature for Glycans guidelines.

Authors:  Sriram Neelamegham; Kiyoko Aoki-Kinoshita; Evan Bolton; Martin Frank; Frederique Lisacek; Thomas Lütteke; Noel O'Boyle; Nicolle H Packer; Pamela Stanley; Philip Toukach; Ajit Varki; Robert J Woods
Journal:  Glycobiology       Date:  2019-08-20       Impact factor: 4.313

3.  Structural Analysis of Heparin-Derived 3-O-Sulfated Tetrasaccharides: Antithrombin Binding Site Variants.

Authors:  Yin Chen; Lei Lin; Isaac Agyekum; Xing Zhang; Kalib St Ange; Yanlei Yu; Fuming Zhang; Jian Liu; I Jonathan Amster; Robert J Linhardt
Journal:  J Pharm Sci       Date:  2016-12-20       Impact factor: 3.534

Review 4.  Synthetic Oligosaccharide Libraries and Microarray Technology: A Powerful Combination for the Success of Current Glycosaminoglycan Interactomics.

Authors:  Vitor H Pomin; Xu Wang
Journal:  ChemMedChem       Date:  2017-12-06       Impact factor: 3.466

5.  The molecular basis of endolytic activity of a multidomain alginate lyase from Defluviitalea phaphyphila, a representative of a new lyase family, PL39.

Authors:  Shiqi Ji; Samuel R Dix; Adli A Aziz; Svetlana E Sedelnikova; Patrick J Baker; John B Rafferty; Per A Bullough; Svetomir B Tzokov; Jon Agirre; Fu-Li Li; David W Rice
Journal:  J Biol Chem       Date:  2019-10-17       Impact factor: 5.157

6.  A polysaccharide lyase from Stenotrophomonas maltophilia with a unique, pH-regulated substrate specificity.

Authors:  Logan C MacDonald; Bryan W Berger
Journal:  J Biol Chem       Date:  2013-11-20       Impact factor: 5.157

7.  Insight into the role of substrate-binding residues in conferring substrate specificity for the multifunctional polysaccharide lyase Smlt1473.

Authors:  Logan C MacDonald; Bryan W Berger
Journal:  J Biol Chem       Date:  2014-05-07       Impact factor: 5.157

8.  Conformational flexibility of PL12 family heparinases: structure and substrate specificity of heparinase III from Bacteroides thetaiotaomicron (BT4657).

Authors:  ThirumalaiSelvi Ulaganathan; Rong Shi; Deqiang Yao; Ruo-Xu Gu; Marie-Line Garron; Maia Cherney; D Peter Tieleman; Eric Sterner; Guoyun Li; Lingyun Li; Robert J Linhardt; Miroslaw Cygler
Journal:  Glycobiology       Date:  2016-09-12       Impact factor: 4.313

9.  Fast and easy method for construction of plasmid vectors using modified quick-change mutagenesis.

Authors:  Jin Woo Bok; Nancy P Keller
Journal:  Methods Mol Biol       Date:  2012

10.  Functional characterization of AlgL, an alginate lyase from Pseudomonas aeruginosa.

Authors:  Emma K Farrell; Peter A Tipton
Journal:  Biochemistry       Date:  2012-12-13       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.